Dr. Connie Eaves - CML - Chronic myeloid leukemia
Professor, Medical Genetics, UBC (University of British Colombia )
Associate Member, Medicine, UBC
Associate Member, Pathology & Laboratory Medicine, UBC
One of her research interest is:
Another goal is to investigate the molecular basis of the altered behavior of the leukemic stem cells in patients with chronic myeloid leukemia, to develop new models of this disease in mice reconstituted with genetically modified human and murine stem cells and to identify new agents for their selective kill.
See more at Dr. Connie J Eaves - Research Interest
ARTICLES
Remembering Dr. Connie Eaves
March 7, 2024, Stem Cell Network
Cell fate decisions in malignant hematopoiesis: leukemia phenotype is determined by distinct functional domains of the MN1 oncogene.
November 17, 2014, PublMed
Ex vivo expansion of normal and chronic myeloid leukemic stem cells without functional alteration using a NUP98HOXA10homeodomain fusion gene.
January 27, 2013, PublMed
Growth arrest specific 2 is up-regulated in chronic myeloid leukemia cells and required for their growth
January 24, 2011, PublMed
Remembering Dr. Connie Eaves
March 7, 2024, Stem Cell Network
Cell fate decisions in malignant hematopoiesis: leukemia phenotype is determined by distinct functional domains of the MN1 oncogene.
November 17, 2014, PublMed
Ex vivo expansion of normal and chronic myeloid leukemic stem cells without functional alteration using a NUP98HOXA10homeodomain fusion gene.
January 27, 2013, PublMed
Growth arrest specific 2 is up-regulated in chronic myeloid leukemia cells and required for their growth
January 24, 2011, PublMed